Webinar: ​​Protein Analytics Strategies for Gene Therapy - From Viral Vector Characterization to Clinical Trials​

Bio-Techne offers a range of analytical tools that support accurate and reproducible protein characterization and quantitation for Gene Therapy.  

Chris Heger, Ph.D., Director of Applications Science at Bio-Techne, provides an introduction to the portfolio with a focus on fit-for-purpose analytical tools for cell and gene therapies. Hiren Patel, Ph.D., Senior Scientist from REGENXBIO Inc., demonstrates how Simple Western™ was utilized successfully to support clinical bioanalytical requirements using principles outlined in the Bioanalytical Method Validation guidance by FDA. Amira Rghei, Ph.D., from Elevate Bio, joins the panel discussion on techniques used in R&D, process development, and clinical trials for gene therapies.

Part 1: Innovative Analytical Tools for Faster Development of Cell and Gene Therapies 

Presented by:

Chris Heger, Ph.D.
Director, Applications Science
Bio-Techne 

Part 2: Quantitation of Dystrophin and Microdystrophin by a Capillary-based Western Immunoassay to Support Clinical Trials for RGX-202, a Novel AAV8-based Gene Therapy for Duchenne Muscular Dystrophy 

Presented by: 

Hiren Patel, Ph.D.
Sr. Scientist
REGENXBIO Inc. 

Part 3: Techniques Used in R&D, Process Development, and Clinical Trials for Gene Therapies 

Hiren Patel, Ph.D., REGENXBIO Inc.
Amira Rghei, Ph.D., Elevate Bio
Chris Heger, Ph.D., Bio-Techne